JP2020519904A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519904A5 JP2020519904A5 JP2020511871A JP2020511871A JP2020519904A5 JP 2020519904 A5 JP2020519904 A5 JP 2020519904A5 JP 2020511871 A JP2020511871 A JP 2020511871A JP 2020511871 A JP2020511871 A JP 2020511871A JP 2020519904 A5 JP2020519904 A5 JP 2020519904A5
- Authority
- JP
- Japan
- Prior art keywords
- timp
- igfbp7
- replacement therapy
- concentration
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023052930A JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762502728P | 2017-05-07 | 2017-05-07 | |
| US62/502,728 | 2017-05-07 | ||
| PCT/US2018/031425 WO2018208684A1 (en) | 2017-05-07 | 2018-05-07 | Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023052930A Division JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020519904A JP2020519904A (ja) | 2020-07-02 |
| JP2020519904A5 true JP2020519904A5 (https=) | 2021-08-19 |
Family
ID=64105628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511871A Pending JP2020519904A (ja) | 2017-05-07 | 2018-05-07 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
| JP2023052930A Pending JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023052930A Pending JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210025875A1 (https=) |
| EP (1) | EP3621987A4 (https=) |
| JP (2) | JP2020519904A (https=) |
| CN (1) | CN110753700A (https=) |
| WO (1) | WO2018208684A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2836218T3 (es) | 2008-10-21 | 2021-06-24 | Astute Medical Inc | Procedimientos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal |
| WO2011075744A1 (en) | 2009-12-20 | 2011-06-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| NZ605698A (en) | 2010-06-23 | 2015-03-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US10935548B2 (en) | 2011-12-08 | 2021-03-02 | Astute Medical, Inc. | Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2 |
| EP3361255B1 (en) | 2013-01-17 | 2020-03-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN110007084B (zh) | 2013-12-03 | 2022-11-18 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
| EP3465201A4 (en) | 2016-06-06 | 2020-08-26 | Astute Medical, Inc. | MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR |
| CN110431422A (zh) | 2017-02-06 | 2019-11-08 | 机敏医药股份有限公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
| CN110709103B (zh) | 2017-04-05 | 2024-02-02 | 机敏医药股份有限公司 | 用于生物学样品中具有改善的性能的timp2的测定法 |
| EP4330681A2 (en) * | 2021-04-30 | 2024-03-06 | Roche Diagnostics GmbH | Igfbp7 marker panels for early detection of sepsis |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (en) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| AU1772992A (en) | 1991-04-10 | 1992-11-17 | Biosite Diagnostics Incorporated | Crosstalk inhibitors and their uses |
| JP3290988B2 (ja) | 1991-04-11 | 2002-06-10 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | 多重リガンドを同時検出する新規接合体及び検定法 |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| WO2011075744A1 (en) * | 2009-12-20 | 2011-06-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2923204A1 (en) * | 2012-10-31 | 2015-09-30 | Astute Medical, Inc. | Quantitative lateral flow assay |
| US11243202B2 (en) * | 2015-04-09 | 2022-02-08 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN108139409B (zh) * | 2015-10-08 | 2020-07-24 | 豪夫迈·罗氏有限公司 | 当在外科手术之前测量时用于预测aki的风险的igfbp7 |
-
2018
- 2018-05-07 CN CN201880040347.5A patent/CN110753700A/zh active Pending
- 2018-05-07 JP JP2020511871A patent/JP2020519904A/ja active Pending
- 2018-05-07 EP EP18797960.4A patent/EP3621987A4/en active Pending
- 2018-05-07 WO PCT/US2018/031425 patent/WO2018208684A1/en not_active Ceased
- 2018-05-07 US US16/611,456 patent/US20210025875A1/en not_active Abandoned
-
2023
- 2023-03-29 JP JP2023052930A patent/JP2023082094A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020519904A5 (https=) | ||
| JP2008501979A5 (https=) | ||
| Mihalj et al. | Recommendations for preoperative assessment and shared decision-making in cardiac surgery | |
| JP2023082094A (ja) | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 | |
| JP2010529468A5 (https=) | ||
| JP2002533680A5 (https=) | ||
| JP2021502573A5 (https=) | ||
| JP2010500535A5 (https=) | ||
| ATE336003T1 (de) | Verfahren zur sepsisdiagnose durch bestimmung von anti-asialo-gangliosid-antikörpern | |
| Lone et al. | The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy | |
| Heuzeroth et al. | Exploratory testing of functional blood oxygenation level dependent-MRI to image the renoprotective effect of Remote Ischaemic PreConditioning during partial nephrectomy | |
| Vrtovsnik et al. | Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations | |
| Zhao et al. | Benefits of early treatment for patients with hepatic myelopathy secondary to TIPS: a retrospective study in Northern China | |
| Kim et al. | Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study | |
| Li et al. | Local factors compared with systemic factors in the formation of bladder uric acid stones | |
| Winkes et al. | Chronic exertional compartment syndrome of the deep posterior lower leg | |
| Afsar et al. | The relationship between aortic knob width and various demographic, clinical, and laboratory parameters in stable hemodialysis patients | |
| JP6727660B2 (ja) | 糖尿病性腎症の判定マーカー | |
| Muttarak et al. | Clinics in diagnostic imaging (97) | |
| Nantau | Epiaortic scanning significantly alters surgical management during aortic instrumentation for cardiopulmonary bypass | |
| Jacoby et al. | Hemothorax | |
| Holmar et al. | New optical method for estimation of protein bound uremic toxins elimination | |
| JP2016535266A5 (https=) | ||
| Kengne | ADVANCE and risk evaluation in diabetes | |
| Castro et al. | 76: Urinary Tract Infection in HTLV-1 Positive Individuals |